Breast Cancer Clinical Trial

Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection

Summary

The objective of this project is to validate a next-generation assay that utilizes both the protein biomarkers of our already established ovarian cancer risk assessment combined with a molecular profile in both germline and early somatic detection.

View Eligibility Criteria

Eligibility Criteria

Key inclusion criteria:

Female subject
18 years of age or older

Cohort A specific inclusion criteria:

• Diagnosed with a pelvic mass

Cohort B specific inclusion criteria:

Diagnosed with a pelvic mass
Undergoing genetic testing through our commercial offering

Cohort C specific inclusion criteria:

• Subject must not have an identifiable adnexal mass and may, or may not, have a family history or a known familial genetic abnormality (germ line or identified in family cancer i.e. somatic DNA mutation) associated with ovarian cancer.

Exclusion Criteria:

n/a

Study is for people with:

Breast Cancer

Estimated Enrollment:

215

Study ID:

NCT04668521

Recruitment Status:

Terminated

Sponsor:

Aspira Women's Health

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Silvana Franco
Austin Texas, 78738, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

215

Study ID:

NCT04668521

Recruitment Status:

Terminated

Sponsor:


Aspira Women's Health

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.